Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:
-- The first section of this topic is shown below --
- Marfan syndrome (MFS) is an inherited disorder of connective tissue.
- Because many features of MFS appear in the general population, specific diagnostic criteria (Ghent nosology) were established and revised, recognizing a constellation of features with major and minor criteria for establishing the diagnosis (1).
- System(s) affected: musculoskeletal, cardiovascular, ocular, pulmonary, skin/integument, connective tissue (dura)
Careful monitoring, as described. Early surgical intervention may reduce the degree of scoliosis.
- Manage pregnancy in MFS as high risk with a cardiologist; prepregnancy evaluation: screening transthoracic echocardiogram for aortic root dilation
- Consider β-blockers in all pregnancies to minimize risk of aortic dilation throughout the pregnancy.
- 1% complication rate if aortic root diameter <40 mm; 10% if >40 mm. Consider elective surgery before pregnancy if >47 mm.
- Avoid spinal anesthesia due to risk of dural ectasia.
- Congenital; although clinical manifestations may be apparent in infancy, affected individuals may not present until adolescence or young adulthood.
- No gender, ethnic, or racial predilection; with advanced paternal age, a slightly increased risk of de novo mutation resulting in MFS in offspring
1/5,000 to 1/10,000 live births
Etiology and Pathophysiology
Genetic abnormality; mutations of the FBN1 (fibrillin) gene. Fibrillin is an extracellular matrix protein widely distributed in elastic and nonelastic connective tissue.
- >1,000 mutations have been identified in the FBN1 gene on chromosome 15q21.1 OMIM 154700 (2).
- MFS is an autosomal dominant condition with complete penetrance and variable expressivity. Apparent nonpenetrance may be due to lack of recognition of MFS in a mildly affected individual.
- FBN1 mutations have been identified in 92% of patients with MFS (3).
- Each child of an affected parent has a 50% chance of inheriting MFS and may be more or less severely affected. 25% of cases result from de novo mutation.
Prenatal diagnosis in families with a known mutation
Commonly Associated Conditions
- High prevalence of obstructive sleep apnea in MFS; may be a risk factor for aortic root dilatation
- Increased prevalence of migraine in MFS